KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9778|33|1|78-87

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.33, Iss.1, 2014-01, pp. : 78-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)

By Assouline Sarit   Cocolakis Eftihia   Borden Katherine L. B.  

Cancers, Vol. 4, Iss. 4, 2012-11 ,pp. : 1161-1179

MDPI

Access to resources Recommend Favorite

Differentiation Therapy of Acute Myeloid Leukemia

By Gocek Elzbieta   Marcinkowska Ewa  

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2402-2420

MDPI

Access to resources Recommend Favorite

Heparan Sulfate D‐Glucosaminyl 3‐O‐Sulfotransferase‐3B1 (HS3ST3B1) Promotes Angiogenesis and Proliferation by Induction of VEGF in Acute Myeloid Leukemia Cells

By  

JOURNAL OF CELLULAR BIOCHEMISTRY, Vol. 116, Iss. 6, 2015-06 ,pp. : 1101-1112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of heat shock protein 70 and NKG2D ligands in acute myeloid leukemia cell lines

By Hromadnikova Ilona   Volchenkov Roman   Sedlackova Lucie   Spacek Martin   Kozak Tomas  

Journal of Receptors and Signal Transduction, Vol. 30, Iss. 3, 2010-06 ,pp. : 161-169

Informa Healthcare

Access to resources Recommend Favorite

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes

By  

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 230, Iss. 8, 2015-08 ,pp. : 1770-1780

John Wiley & Sons Inc

Access to resources Recommend Favorite